McDermott Will & Schulte has a busy practice representing investments funds, companies and individual shareholders in post M&A and shareholders’ conflicts, while also assisting companies in commercial litigation and industrial manufacturing and product liability disputes. The team notably acts for several pharmaceutical laboratories in proceedings regarding the development of their drug products. The practice is headed by Nicolas Faguer,
Legal 500 redaktioneller Kommentar
Praxisleitung

Nicolas Faguer

Weitere Kernanwält*innen

Adrien Gros